Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study
August 23, 2017 07:00 ET
|
Asterias Biotherapeutics
FREMONT, Calif., Aug. 23, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that...
Asterias Biotherapeutics Reports Second Quarter Financial Results and Reviews Recent Clinical Progress and Corporate Developments
August 14, 2017 16:10 ET
|
Asterias Biotherapeutics
- Achieved meaningful progress with key clinical programs; multiple milestones anticipated during remainder of 2017- - Conference Call and Webcast Today, August 14, at 4:30 p.m. ET - FREMONT,...
Asterias Announces Major AST-VAC2 Development Milestone: First cGMP-Compliant Lot Successfully Manufactured to Support First Clinical Study of AST-VAC2
August 14, 2017 07:00 ET
|
Asterias Biotherapeutics
FREMONT, Calif., Aug. 14, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Cancer...
Asterias Enrolls First Patient in Final Cohort of SCiStar Clinical Trial
August 09, 2017 07:00 ET
|
Asterias Biotherapeutics
FREMONT, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced enrollment...
Former Quadriplegic Enrolled in Asterias’ SCiStar Study to Throw Ceremonial First Pitch at Major League Baseball Game
August 08, 2017 07:00 ET
|
Asterias Biotherapeutics
FREMONT, Calif., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST) today announced that Lucas Lindner of Eden, Wisconsin, a quadriplegic patient who has regained...
Asterias Biotherapeutics to Present at Canaccord Genuity Growth Conference on August 10, 2017
August 07, 2017 07:00 ET
|
Asterias Biotherapeutics
FREMONT, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Mike...
Asterias Biotherapeutics Opens Two Additional Clinical Sites for AST-OPC1 SCiStar Study
August 03, 2017 07:00 ET
|
Asterias Biotherapeutics
FREMONT, Calif., Aug. 03, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that two...
Asterias Biotherapeutics to Report Second Quarter Results on August 14, 2017
July 31, 2017 07:00 ET
|
Asterias Biotherapeutics
FREMONT, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company focused on the emerging field of regenerative medicine, today announced that...